Skip to main content
SpringerLink
Log in

Gliomatosis cerebri evaluated by 18Fα-methyl tyrosine positron-emission tomography

  • Diagnostic Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Gliomatosis cerebri is a rare condition in which an infiltrative glial neoplasm spreads through the brain with preservation of the underlying structure. CT and MRI show diffuse abnormal density or signal, without mass effect, and because these findings are nonspecific, it is difficult to make a definitive diagnosis. Our purpose was to assess the usefulness of a new tumour-detecting amino acid tracer for positron-emission tomography (PET), L-[3-18F] α-methyl tyrosine (FMT), in patients with gliomatosis cerebri. We performed FMT PET, fluorodeoxyglucose FDG PET and MRI eight patients with gliomatosis cerebri and six with non-neoplastic disease, whose MRI also showed diffuse high signal on T2-weighted images. Standardised uptake (SUV) of FMT and FDG in the area of gliomatosis was obtained and the tumour-to-normal cortex (T/N) ratio of this was compared. The tumours were shown on FMT PET as areas of increased uptake, except in one patient with severe intracranial hypertension. There were significant differences between the SUV of FMT and the T/N ratio of FMT in patients and in controls (both P<0.01), and between the T/N ratio of FMT and FDG in patients (P <0.01). Increased uptake of FMT PET strongly suggests neoplasia. FMT PET is valuable for differentiating gliomatosis cerebri from non-neoplastic diseases showing similar diffuse high signal on T2-weighted images and little contrast enhancement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1a–d.
Fig. 2a–e.
Fig. 3a, b.
Fig. 4a–c.

Similar content being viewed by others

References

  1. Bebin J, Tytus JS (1956) Gliomatosis cerebri–case report. Neurology 6: 815–822

    Google Scholar 

  2. Couch JR, Weiss SA (1974) Gliomatosis cerebri. Reports of four cases and review of the literatures. Neurology 24: 504–511

    CAS  PubMed  Google Scholar 

  3. Dunn J Jr, Kernohan JW (1956) Gliomatosis cerebri. Arch Pathol 64: 82–91

    Google Scholar 

  4. Artigas J, Cervos-Navarro J, Iglesias JR, Ebhardt G (1985) Gliomatosis cerebri: clinical and histological findings. Review article. Clin Neuropathol 4: 135–148

    CAS  PubMed  Google Scholar 

  5. Dickson DW, Horoupian DS, Thal LJ, Lantos G (1988) Gliomatosis cerebri presenting with hydrocephalus and dementia. AJNR 9: 200–202

    CAS  Google Scholar 

  6. Malamud N, Wise BL, Jones OW Jr (1952) Gliomatosis cerebri. J Neurosurg 9: 409–417

    Google Scholar 

  7. Kleihues P, Burger PC, Scheihauer BW (1993) The new WHO classification of brain tumors. Brain Pathol 3: 255–268

    CAS  PubMed  Google Scholar 

  8. Lantos PL, Bruner JM (2000) Gliomatosis cerebri. In: Kleihues P, Cavenee WK (eds) WHO classification. Tumours of the nervous system. IARC Press, Lyon, pp 92–93

  9. Geremia GK, Wollman R, Foust R (1988) Computed tomography of gliomatosis cerebri–case report. J Comput Assist Tomogr 12: 698–701

    CAS  PubMed  Google Scholar 

  10. Gottesman M, Laufer H, Patel M (1991) Gliomatosis cerebri: a case report. Clin Neuropathol 10: 303–305

    CAS  PubMed  Google Scholar 

  11. Di Chiro G, DeLaPaz RL, Brooks RA, et al (1982) Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323–1329

    PubMed  Google Scholar 

  12. Dexter MA, Parker GD, Besser M, Ell J, Fulham MJ (1995) MR and positron emission tomography with fludeoxyglucose F 18 in gliomatosis cerebri. AJNR 16: 1507–1510

    CAS  Google Scholar 

  13. Felsberg GJ, Silver SA, Brown MT, Tien RD (1994) Gliomatosis cerebri: radiologic pathologic correlation. AJNR 15: 1745–1753

    CAS  Google Scholar 

  14. Shin YM, Chang KH, Han MH, et al (1993) Gliomatosis cerebri: comparison of MR and CT features. Am J Roentgenol 161: 859–862

    CAS  Google Scholar 

  15. Ogawa T, Shishido F, Kanno I, et al (1993) Cerebral glioma: evaluation with methionine PET. Radiology 186: 45–53

    CAS  PubMed  Google Scholar 

  16. Tomiyoshi K, Amed K, Muhammad S, et al (1997) Synthesis of new fluorine-18 labeled amino acid radiopharmaceutical: L-18F-alpha-methyl tyrosine using separation and purification system. Nucl Med Commun 18: 169–175

    CAS  PubMed  Google Scholar 

  17. Inoue T, Shibasaki T, Oriuchi N, et al (1999)18F-α-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med 40: 399–405

    CAS  PubMed  Google Scholar 

  18. Inoue T, Koyama K, Oriuchi N, et al (2001) Detection of malignant tumors: whole-body PET with fluorine 18α-methyl tyrosine versus FDG–preliminary study. Radiology 220: 54–62

    CAS  PubMed  Google Scholar 

  19. Langen KJ, Coenen HH, Roosen N, et al (1990) SPECT studies of brain tumors with L-3-[123I]iodo-α-methyl tyrosine: comparison with PET, 124IMT, and first clinical results. J Nucl Med 31: 281–286

    CAS  PubMed  Google Scholar 

  20. Langen KJ, Roosen N, Coenen HH, et al (1991) Brain and brain tumor uptake of L-3-[123I]iodo-α-methyl tyrosine: comparison with natural L-amino acids. J Nucl Med 32: 1225–1228

    CAS  PubMed  Google Scholar 

  21. Inoue T, Tomiyoshi K, Higuchi T, et al (1998) Biodistribution studies on L-3-(18F)fluoro- α-methyl tyrosine: a potential tumor-detecting agent. J Nucl Med 39: 663–667

    CAS  PubMed  Google Scholar 

  22. Amano S, Inoue T, Tomiyoshi K, et al (1998) In vivo comparison of radiopharmaceuticals in detecting breast cancer. J Nucl Med 39: 1424–1427

    CAS  PubMed  Google Scholar 

  23. Meikle SR, Bailey DL, Hooper PK, et al (1995) Simultaneous emission and transmission measurement for attenuation correction in whole-body PET. J Nucl Med 36: 1680–1688

    CAS  PubMed  Google Scholar 

  24. Nevin S (1938) Gliomatosis cerebri. Brain 61: 170–191

    Google Scholar 

  25. Spagnoli M, Grossman RI, Packer RJ, et al (1987) Magnetic resonance imaging determination of gliomatosis cerebri. Neuroradiology 29: 15–18

    CAS  PubMed  Google Scholar 

  26. Souba WW, Pacitti AJ (1992) How amino acids get into cells: mechanisms, models, menus, and mediators. J Parenter Enteral Nutr 16: 569–578

    CAS  Google Scholar 

  27. Pruim J, Willemsen ATM, Molennar WM, et al (1995) Brain tumors: L-[11C]-tyrosine PET for visualization and quantitation of the protein synthesis rate. Radiology 197: 221–226

    CAS  PubMed  Google Scholar 

  28. Coenen HH, Kling P, Stocklin G (1989) Cerebral metabolism of L-[2-18F]fluorotyrosine: a new PET tracer of protein synthesis. J Nucl Med 30: 1367–1372

    CAS  PubMed  Google Scholar 

  29. Kawai K, Fujibayashi Y, Saji H, et al (1991) A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodoalpha-methyl-L-tyrosine. J Nucl Med 32: 819–824

    CAS  PubMed  Google Scholar 

  30. Kawai K, Fujibayashi Y, Yonekura Y, et al (1995) Canine SPECT studies for cerebral amino acid transport by means of123I-3-iodo-α-methyl-L-tyrosine and preliminary kinetic analysis. Ann Nucl Med 9: 47–50

    CAS  PubMed  Google Scholar 

  31. Langen KJ, Ziemons K, Kiwit JCW, et al (1997) 3-[123I]Iodo-α-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med 38: 517–522

    CAS  PubMed  Google Scholar 

  32. Kaschten B, Stevenaert A, Sadzot B, et al (1998) Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and /or carbon-11-methionine. J Nucl Med 39: 778–785

    CAS  PubMed  Google Scholar 

  33. Delbeke D, Meyerowitz C, Lapidus RL, et al (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195: 47–52

    CAS  PubMed  Google Scholar 

  34. Oriuchi N, Tamura M, Shibazaki T, et al (1993) Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis an proliferative activities. J Nucl Med 34: 2087–2089

    Google Scholar 

  35. Mineura K, Sasajima T, Suda Y, Kowada M, Shishido F, Uemura K (1989) Early and accurate detection of primary cerebral glioma with interfibrillary growth using11C-L-methionine position emission tomography. J Med Imaging 3: 192–196

    Google Scholar 

  36. Shintani S, Tsuruoka S, Shiigai T (2000) Serial positron emission tomography (PET) in gliomatosis cerebri treated with radiotherapy: a case report. J Neurol Sci 173: 25–31

    Article  CAS  PubMed  Google Scholar 

  37. Mosskin M, Ericson K, Hindmarsh T, et al (1989) Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 30: 225–232

    CAS  PubMed  Google Scholar 

  38. Brock CS, Meikle SR, Price P (1997) Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? Eur J Nucl Med 24: 691–705

    Google Scholar 

  39. Rise IR, Risoe C, Kirkeby OJ (1998) Cerebrovascular effects of high intracranial pressure after moderate hemorrhage. J Neurosurg Anesthesiol 10: 224–230

    CAS  PubMed  Google Scholar 

  40. De Bray JM, Le Jeune JJ, Pourcelot L, Saumet JL, Jallet P (1994) 99mTc-HMPAO cerebral scintigraphy and transcranial pulsed Doppler in acute intracranial hypertension in rabbits. Br J Radiol 67: 540–545

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, Gunma University School of Medicine, 3-39-15 Shouwa-machi, Maebashi, 371-8511, Gunma, Japan

    N. Sato & J. Aoki

  2. Department of Radiology, Yokohama City University, Yokohama, Japan

    T. Inoue

  3. Department of Nuclear Medicine, Gunma University School of Medicine, Maebashi, Gunma, Japan

    K. Tomiyoshi, N. Oriuchi & K. Endo

  4. Department of Neurosurgery, Gunma University School of Medicine, Maebashi, Gunma, Japan

    A. Takahashi, T. Otani, H. Kurihara & T. Sasaki

Authors
  1. N. Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Tomiyoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Aoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Oriuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Otani
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Kurihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T. Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K. Endo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Sato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sato, N., Inoue, T., Tomiyoshi, K. et al. Gliomatosis cerebri evaluated by 18Fα-methyl tyrosine positron-emission tomography. Neuroradiology 45, 700–707 (2003). https://doi.org/10.1007/s00234-003-1057-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-003-1057-2

Keywords

Search

Navigation